Bladder Preservation for Muscle Invasive Bladder Cancer - Wikidata - wikimedia - TriplyDB

Bladder Preservation for Muscle Invasive Bladder Cancer

Bladder Preservation for Muscle Invasive Bladder Cancer

http://www.wikidata.org/entity/Q26744750

about

Opa interacting protein 5 acts as an oncogene in bladder cancer.Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice.Can a diagnosis of bladder cancer motivate positive lifestyle changes-and prevent recurrent disease?

P2860

Q40116026-91D7563E-2D11-419B-8D70-0DB02FF80898 Q46908539-F2B00683-5DC1-48BE-B9C1-A9C245CA3175 Q55399649-95A82E23-DBEE-42E2-8D22-B8381FEA861E

P2860

Bladder Preservation for Muscle Invasive Bladder Cancer

http://www.wikidata.org/entity/Q26744750

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Bladder Preservation for Muscle Invasive Bladder Cancer

@ast

Bladder Preservation for Muscle Invasive Bladder Cancer

@en

Bladder Preservation for Muscle Invasive Bladder Cancer

@nl

type

label

Bladder Preservation for Muscle Invasive Bladder Cancer

@ast

Bladder Preservation for Muscle Invasive Bladder Cancer

@en

Bladder Preservation for Muscle Invasive Bladder Cancer

@nl

prefLabel

Bladder Preservation for Muscle Invasive Bladder Cancer

@ast

Bladder Preservation for Muscle Invasive Bladder Cancer

@en

Bladder Preservation for Muscle Invasive Bladder Cancer

@nl

P1433

Q26744750-C7B4CF78-D302-4109-A2F2-3ED8B127B998

P1476

Q26744750-BCCA638F-C6A0-45B3-B514-986EFF7365FB

P2093

Q26744750-489B2A36-9473-47EE-9E8E-786E8CC4D7E9

P2860

Q26744750-0CB4DED4-CE5A-48BE-8734-1EDB2ABACF25

Q26744750-114181FC-B6C0-40D6-BB87-1759E84CA225

Q26744750-1A47B65D-95D9-4498-B1C6-F54EB9706231

Q26744750-1F2CAF24-EFAC-4654-B55F-B2554F169F6E

Q26744750-2075171D-417D-4BAB-9378-79B2B0F2E5EC

Q26744750-2AF7A0F5-2A36-4CD7-9FBD-7C3F98C903BE

Q26744750-2D7E2CC9-4A67-4B2E-A11A-B25CC83BC6EC

Q26744750-3180DDA1-B094-4603-8734-86E93FFD6F82

Q26744750-34CC4AED-2471-49D0-9C12-02BA59DAC800

Q26744750-39F6D7E2-EED6-42A9-A28B-CACECB0AE01D

P304

Q26744750-48EF75CD-7ABE-4250-8DAB-21906328A1D3

P31

Q26744750-8C1F5371-803C-4B05-A89C-49398C524A1B

P3181

Q26744750-E8B37F88-73B2-4BAF-ABA3-CB55A700D9A4

P356

Q26744750-ED439737-813E-4179-B696-4564F19F56AE

P407

Q26744750-30443122-2B91-48DF-B055-D8ED2F9476EC

P433

Q26744750-D11B555D-4D1C-4772-A0FE-D693751351A1

P478

Q26744750-AF475A52-80B4-4FED-895D-24CE7BC592C0

P50

Q26744750-7AB01DFF-F554-42AC-A3B4-666C0E504618

P577

Q26744750-FD4E3710-BEFB-4AFA-9BFB-C1728CD54955

P698

Q26744750-C553907F-A4F9-4556-AED0-D574A6CC6471

P932

Q26744750-511FA426-829C-41B0-88D0-DA64B3808676

P3181

P356

P1433

Bladder Cancer (Amsterdam, Netherlands)

P1476

Bladder Preservation for Muscle Invasive Bladder Cancer

@en

P2093

Arafat Mirza

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.

External beam radiation plus concurrent intra-arterial chemotherapy with low dose cisplatin for muscle invasive bladder cancer.

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder.

Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy

Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research.

P304

151-163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2031481

http://www.w3.org/2001/XMLSchema#string

P356

10.3233/BLC-150025

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Ananya Choudhury

P577

2016-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27376137

http://www.w3.org/2001/XMLSchema#string

P932

4927909

http://www.w3.org/2001/XMLSchema#string